A KOSDAQ-listed maker of secondary-battery and display equipment has bought a cosmetics filling-and-packaging automation company for USD 17.7 million, in a deal brokered by a Korean state credit-guarantee fund. It is a small transaction, and it describes where the K-beauty industry's constraint actually sits far better than the export figures do. The thing that stops an indie brand scaling into a new market is almost never the formulation. It is the filling line. Who bought Irae, and for how much? On 21 August 2026 the Korea Technology Finance Corporation announced that it had brokered the sale of a 100 percent stake in Irae — a maker of automated cosmetics filling and packaging equipment, and the surviving entity of an earlier merger — together with the business division of Irae Engineering. The buyer was APS Innovation, a KOSDAQ-listed manufacturer of production equipment for secondary batteries and displays. The package price was USD 17.7 million. That is a small number in a year when Korean cosmetics exports are being counted in billions. It is also the most instructive Korean cosmetics transaction of the week, precisely because it involves no brand, no founder story and no retailer. The equipment tier: Irae's automated filling and packaging business changed hands for USD 17.7 million on 21 August. Why is line changeover the real K-beauty bottleneck? Ask an overseas brand why its Korean launch slipped a quarter and you will rarely be told the formulation failed. You will be told the minimum order quantity was higher than expected, or that the plant could not open a line slot until after the sunscreen season, or that the pack format required a changeover the filler was unwilling to schedule for a small run. Indie brands run short batches across many stock-keeping units and change their packaging often. That is a machine problem — specifically, a problem of how quickly a line can be reconfigured, and how many formats it can carry without losing throughput. Chemistry is not the bottleneck. Changeover is. What did TPG actually change at Samhwa? This is why capital has been moving steadily down the stack, away from brands and towards the companies that make the parts and the machines. The clearest case is Samhwa, the dispenser and bottle manufacturer founded in 1977. TPG acquired Samhwa and four affiliated entities in November 2023; less than two years later, KKR completed the purchase at a valuation of USD 528 million. What TPG changed in between was the mix. Dispensers went to 65 percent of sales, commodity bottles were pared back, and the company launched an online custom-order platform for indie beauty brands allowing real-time design and procurement — something KED Global described as akin to a foundry model in semiconductors. A foundry is exactly the right analogy. It is also a manufacturing analogy, not a marketing one. Under TPG, dispensers rose to 65 percent of Samhwa's sales and commodity bottles were pared back. Are the Korean packaging makers reporting the same pattern? They are. KED Global's 14 August 2026 report on Korean cosmetics packaging makers records that Kolmar subsidiary Yonwoo saw second-quarter profit jump nearly ninefold, with Pumtech and ChangShin posting record quarterly earnings. None of those three sells anything to a consumer under its own name. Why would a battery equipment maker want a cosmetics filling line? What makes the APS Innovation purchase worth reading closely is the identity of the buyer. Nothing about secondary-battery or display equipment is cosmetic. What transfers is precision machinery, motion control, and the discipline of running high-mix production lines to tight tolerances — competences Korean industry built in electronics and is now carrying sideways. APS Innovation said it intends to combine Irae's filling and packaging automation with its own precision machinery and control capabilities, and to route Irae's equipment through operational bases it already holds in the United States, Canada and China. Read that way, Korea's manufacturing advantage in cosmetics is not really a beauty competence at all. It is capital-equipment competence arriving from an adjacent sector. How do small Korean manufacturers actually get sold? This is the detail foreign partners consistently misread. The deal was not run by a bank. APS Innovation registered its acquisition interest on the Korea Technology Finance Corporation's public-private M&A platform, and the corporation connected it with InterCapital Partners, a private advisory firm participating in the platform, which then supported the structuring, due diligence, negotiation of terms and signing. That is the ordinary route by which a small, founder-held Korean technology company changes hands. Samhwa is the same story in a larger frame: KED Global reports that TPG spent more than two years courting Samhwa's founder, who was grappling with succession concerns, and that the deal was sealed on a commitment to consolidate a fragmented family-run structure into a professional company. Yonwoo's second-quarter profit rose nearly ninefold, with Pumtech and ChangShin at record quarterly earnings — none of them a consumer brand. What should you check before signing with a Korean supplier? Put those two observations together and the practical advice writes itself. If you are building a Korean supply relationship, your diligence should reach past the formulator to the filler: how many formats the line carries, what a changeover costs in hours, who owns the equipment, and who services it. And if you are assessing a Korean supplier as an asset, ask who succeeds the founder. That question decides more Korean mid-cap transactions than price does. So is K-beauty a brand story or an industrial one? The larger point is the one the export tables obscure. Plenty of money still chases Korean brands, and some of it has been lost there — KED Global has written at length about the global groups that bought hot Korean labels and then struggled with them. That case is real and should not be waved away. What has changed is that the supply tier now clears at prices the brand tier used to command, and it clears to buyers who are pricing a manufacturing capability rather than a consumer following: a dispenser specialist, a packaging group, and now a battery-and-display equipment maker buying a filling line business with money that could as easily have gone into cells. The brands are the visible layer. A growing share of the returns is being made underneath them.

Estée Lauder wrote USD 375 million off Dr.Jart+ in fiscal 2025, then ran a sale process for the brand, took bids, and decided in July 2026 to keep it and shrink the team instead. The company's fiscal 2026 results, published on 19 August 2026, name Dr.Jart+ in exactly two places. This is the clearest public record of what happens to a Korean brand after the exit everyone treats as the finish line. Dr.Jart+ What did Estée Lauder's fiscal 2026 results actually say? The Estée Lauder Companies reported net sales up 5% to USD 15.0 billion for the year ended 30 June 2026. Organic sales rose 3%. Fourth-quarter organic growth accelerated to 5%, a fourth consecutive quarter of growth. Adjusted operating margin expanded 320 basis points, to 11.2%. Gross margin reached 75.5%. "We reignited growth with organic sales rising 3%, driven by the breadth of growth across brands, and achieved significant operating margin expansion," said President and CEO Stéphane de La Faverie. Breadth across brands. The release names which ones. Fragrance grew 10% organically, led by Le Labo, TOM FORD and KILIAN PARIS. Skin Care rose 4% organically, led by La Mer, The Ordinary and Estée Lauder. Jo Malone London and TOM FORD joined the roster of billion-dollar brands, taking the count to six. Dr.Jart+ is named in exactly two places in that release. Once in the paragraph listing every brand the company sells. Once in an impairment footnote. A minimalist composition featuring cylindrical containers with colorful lids arranged on a shelf, ⓒinhoocho.com How much did Estée Lauder write off against Dr.Jart+? USD 375 million, in fiscal 2025. The footnote is worth reading twice. The company determined that the carrying value of the Dr.Jart+ trademark exceeded its estimated fair value and recorded an USD 83 million trademark impairment. Alongside it sits a USD 292 million impairment against the brand's customer list intangible. That USD 375 million accounts for the whole "other intangible asset impairments" line for the entire Asia/Pacific region that year. One Korean asset, the full regional figure. What did Estée Lauder pay for Have & Be Co. in 2019? In November 2019, Estée Lauder agreed to buy the two-thirds of Have & Be Co. it did not already own, following a minority investment made in December 2015. Have & Be carried a total enterprise value of approximately USD 1.7 billion. It was the company's first acquisition of an Asia-based beauty brand. Dr.Jart+ was then expected to exceed USD 500 million in net sales for calendar 2019. Set the two numbers beside each other and the shape of the thing is obvious. What is not obvious, and what the footnote actually explains, is how it happened. Dr.Jart+ Why did the value disappear? Not through neglect. Through decisions. The impairment note records that a decision was made "in the prior year in the reporting unit's operating plan to exit the travel retail channel," and that a revised strategy followed involving "increased direct investment in other areas of the business, including in mainland China, to support the brand's future growth." Growth in key geographies then came in below expectation — specifically, the note says, in mainland China and Korea — and internal forecasts were revised downwards. Read that as an operator rather than an analyst. Travel retail was not a side channel for a Korean skincare brand in the late 2010s. For a great many of them it was the demand engine. A new owner looked at it, judged it low-quality revenue, and closed it. That is a defensible call on its own terms, and plenty of Western portfolio managers made the same one in the same window. But the growth curve the buyer had paid for was generated by that channel. Removing it and redirecting spend into direct mainland China investment was not housekeeping. It produced a different company. Abstract illustration depicting industrial pipes releasing liquid into a container, ⓒinhoocho.com Did Estée Lauder sell Dr.Jart+? No. It nearly did, and then it did not — and the sellers had no vote in either outcome. In November 2025, Axios reported that Estée Lauder was exploring a sale of Dr.Jart+, with the brand expected to generate around USD 150 million in 2025 revenue. By June 2026, KED Global reported that The Founders Inc., the Korean company behind Anua, was looking at buying it, with the brand discussed in the market at around USD 130 million. Then, in July 2026, a leaked internal memo from Stéphane de La Faverie — the contents of which Estée Lauder confirmed to BeautyMatter — said the company would keep it. Too Faced, Smashbox and Dr.Jart+ would all be retained and restructured instead. Dr.Jart+ stays in South Korea with a leaner, more agile team, focused on innovation and selected regions. That is the complete arc, and it is the part worth sitting with. A Korean brand was bought, revalued, written down, put on the block, priced by the market at under a tenth of its 2019 enterprise value, taken off the block, and shrunk — across six years in which every one of those decisions was made about it and none by it. Modern geometric artwork depicting stacks of colorful shipping containers, ⓒinhoocho.com What does a strategic exit actually buy? A strategic acquirer buys a growth curve. It does not buy — and cannot be made to buy — a commitment to keep generating that curve the same way. Every restructuring programme is a concentration exercise, and Estée Lauder's has been unusually explicit: USD 1.2 billion in annual gross benefits at the high end of the range, a net reduction of approximately 10,000 positions, six billion-dollar brands. Concentration is how the margin came back. Concentration also means something gets deprioritised, and the likeliest candidate is the asset whose operating logic the buyer understands least. What should a Korean founder ask before a strategic sale? None of this is an argument against selling. It is an argument for a narrower question in the room than most Korean sellers ask. Not what is the multiple, but: which channel decisions survive closing? Who holds the pricing ladder in Asia travel retail on day one? What happens to the assumption base if the acquirer decides a channel is dilutive? Because the honest answer to the last one is now on file, in a footnote, at USD 375 million.

LG Household & Health Care agreed on 24 August 2026 to sell The Avon Company, its entire North American Avon business, to Stratford Worldwide, an affiliate of the investment firm Regent, for a reported USD 6 million. LG H&H paid USD 125 million for the business in April 2019 and subsequently lent it a further USD 205.5 million, which it is now converting to equity. The price is not evidence that direct selling has failed — Mary Kay announced an expansion of the same model three days earlier — but evidence that the Avon brand was never a single asset, and that what each buyer actually paid for was the selling operation underneath the name. Avon's value sat in a standing network of independent representatives, not in the name above it. How much did LG H&H lose on Avon North America? Set the sale price against what the business cost. LG H&H agreed to buy Avon's North American operation in April 2019 for USD 125 million. It then lent the unit a further USD 205.5 million, and as part of this transaction it is converting the entire loan to equity — no cash moves, and no change in ownership stakes. Seoul Economic Daily reports the unit has been loss-making every year since 2021. No filing adds those two figures together, so treat the total as mine rather than the company's: roughly USD 330 million in, USD 6 million out. Under two per cent. The Korea Herald notes that the exact sale price is only fixed at closing, which is expected on 1 September 2026. Avon Skincare Collection, ⓒAvon Does the Avon sale prove direct selling is dead? No, and this is where most of the commentary goes wrong. Start with the channel, because it is the easiest variable to exonerate. Three days before the LG H&H filing, on 21 August, Mary Kay announced an acceleration of exactly the model LG H&H is walking away from — My Shop, a cloud-first platform giving its Independent Beauty Consultants personalised online storefronts wired into the company's e-commerce, payment, fulfilment and social media capabilities. It launched in the United States and Germany in 2025 and reached Canada, Mexico and Spain this summer. Whatever is wrong at Avon North America, "people selling beauty products to people they know" is not it. Nor did LG H&H mistreat the model. The joint release describes it as having supported Avon North America through product innovation, digital and operational capability, and "ongoing modernization of the Social Selling business model." And the buyer is explicit about what it wants. Michael A. Reinstein, Regent's founder, chairman and chief executive: "Our job now is to put the scale of the combined business behind better products, sharper execution and a stronger earning opportunity for the people who sell them." Read where that sentence lands. Not on the brand. On the sellers. What did LG H&H actually buy in 2019? Not "Avon". It bought New Avon LLC — one geographic slice of a business already cut apart three years earlier, when Avon's North American and international operations separated in 2016. The seller was no Avon parent handing over the family jewels; the controlling stake came from Cerberus Capital Management, the private equity firm that had held it since the split. The former parent, Avon Products, later filed for Chapter 11 in Delaware in August 2024, citing pandemic pressures and a mass of talc litigation. So: a single territory's operating company, carrying a name it shared with entities it did not control, in a category where the real asset — a standing network of independent representatives and the relationships each of them personally owns — is not transferable and not ownable in any conventional sense. Sold for about $6 million, with the exact figure fixed only at closing. Who owns the Avon brand now? More than one party, and that is the whole point. Eight months ago the other slice moved too. Natura &Co completed the sale of Avon International to Regent on 31 December 2025 — widely reported as a January 2026 acquisition — for a nominal one pound, leaving behind a secured credit facility of USD 25 million available until December 2026. Russia was excluded and remains for sale. And Natura kept Latin America outright. As Premium Beauty News records, "the Avon brand and all of its operations in Latin America, including intellectual property rights, remain the property of the Natura group." Sit with that. The Avon brand is not one asset with one owner. Its Latin American rights belong to a Brazilian group. Everything else has just been consolidated under a private investment firm, acquired in two pieces, from two different sellers, eight months apart, at a nominal pound and at roughly USD 6 million. An asset that fragments like that was never a single store of value. It was a label sitting on whatever selling operation happened to be underneath it in each market, and the price in each case tracked the operation, not the label. Why does Regent want Avon at these prices? Because Regent is buying something LG H&H could not use. Regent is not paying for a name it could have licensed; it is buying seller networks and putting them under one roof. On closing, expected on 1 September, the reunified business will be led by Lisa Siders, currently chief operating officer of Avon International and Regent's operating partner for Avon. An operator, not a brand executive. Recognition, then, is not equity. It becomes equity only in the hands of someone who also holds the mechanism that turns a name into a transaction — and who is in the business of running that mechanism. LG H&H is not. Its stated reason for exiting is to concentrate on brands like Dr. Groot and Belif, which reach customers through retail and digital channels. That is a coherent company. It simply had nothing useful to offer a business whose distribution is people selling to people they already know. What Regent is actually buying: the seller networks, consolidated under one owner. What does this mean for Korean beauty brands? A great many Korean brands are being valued as though the name is carrying the business. It generally is not. The business is carried by a buyer at a retailer, a platform's search ranking, a distributor's book, an algorithm — mechanisms the brand does not own, cannot move and in most cases cannot even audit. That is a workable position, right up to the moment somebody wants to buy you, or the mechanism changes hands. The number to keep is not USD 6 million. It is the ratio: roughly USD 330 million in, USD 6 million out. That is the price of discovering, seven years late, that a name and the machine underneath it are two different assets, and that you only bought one of them.

Korea's National Assembly passed the Act on the Fostering and Support of the Cosmetics Industry on 20 August 2026. The only genuinely new instrument in it — certification as an "innovative cosmetics company" — has its qualifying thresholds left entirely to presidential decree. That means the law that decides who benefits will be written over the next twelve months, not last week, and if it is written as an R&D-spending gate it will certify the manufacturers and miss the exporters. The Korea National Assembly building illuminated against the night sky What does Korea's Cosmetics Industry Promotion Act actually do? It gives the Ministry of Health and Welfare a standing mandate over cosmetics as an industry, running alongside the Ministry of Food and Drug Safety's existing mandate over cosmetics as a safety question under the Cosmetics Act. Korea now has two ministries with two opposite jobs on the same product: one polices it, one promotes it. The mechanics are conventional. The health minister draws up a five-year comprehensive plan, confirmed by a new committee sitting under him. A state-of-the-industry survey runs every three years. There are provisions for industry clusters, a comprehensive support centre, an integrated information system, specialist workforce training, support for the packaging and raw-material tiers, and trademark cooperation with major export markets. The Act takes effect one year after promulgation, which itself follows cabinet deliberation. Read that list again and notice how much of it already exists. The Korea Health Industry Development Institute (KHIDI) and the Korea Cosmetic Industry Institute have both run cosmetics support programmes for years — the Korean trade press covering the bill notes that the ministry's cosmetics policy is currently split between the two, and that sorting out which body does what is now the live administrative question. Plans, committees, portals and centres are the standard furniture of Korean industrial policy. They get built, they publish, and the export figure does what it was going to do anyway. A lone individual stands apart, contemplating the path less taken as a long line of people funnels through a turnstile, symbolizing conformity and individual choice. What is the "innovative cosmetics company" certification? It sits in Article 16, and it is the one genuinely new instrument in the Act. A company qualifies by investing above a set threshold in cosmetics R&D, or by meeting criteria related to overseas-expansion capability. Note the or. The Korean bill text is disjunctive — two independent routes — and everything below turns on that. Some English coverage has rendered it as R&D investment alongside export capacity, which reads as a single combined test. It is not one. The health minister certifies, after deliberation by the new committee. Certification runs three years and carries preferential treatment in national and local government support programmes. KHIDI is named in the bill as the presumptive implementing agency for the certification function. Then the sentence that matters: the investment threshold, the company categories and the support methods are all left to presidential decree. So the law that passed on 20 August is a container. The decree drafted over the next twelve months is the law. Why does the R&D investment threshold matter so much? Because of who actually generates Korea's cosmetics export revenue. Korean cosmetics exports hit USD 11.4 billion in 2025, a record year. The Ministry of Food and Drug Safety's provisional figure for the first half of 2026 is USD 7 billion, up 27.3 percent year on year and the highest first half on record. Over the same period, the share of total cosmetics exports made by small and medium-sized enterprises rose from 56.2 percent in 2022 to 72.8 percent in 2025. That last number is the whole problem. The companies producing close to three-quarters of the export value are indie brands, and the structural reason they can export at all is that they do not carry their own R&D. Kolmar Korea and Cosmax hold the formulation, the stability work and the technical dossiers. The brand holds the concept, the channel and the localising. This is not a weakness in the model. It is the model. It is a good division of labour, and it is the reason a Korean brand can get from incorporation to a foreign retail shelf without ever owning a laboratory. Now measure that company by R&D spend. It scores nothing. Its ODM scores well — and in the third week of August 2026, Cosmax and Cosmecca Korea both came within touching distance of 52-week highs intraday, with Kolmar Korea climbing alongside them. That tier of the supply chain is not what is waiting on a certificate. A minimalist illustration depicting an industrial scene with shipping containers and a factory under a muted sky, blending geometric shapes and earthy tones. What happened when Korea tried this in pharmaceuticals? We do not have to speculate about how an R&D-spending gate behaves, because Korea has already run this exact instrument. The "innovative pharmaceutical company" certification has existed since 2012 under the Special Act on the Fostering and Support of the Pharmaceutical Industry. Same ministry. Same implementing agency. This year the ministry raised the R&D-investment ratio requirement by two percentage points across the board — to 9 percent of pharmaceutical revenue for companies below KRW 100 billion in sales, and 7 percent for those above it — with a three-year grace period before the tightened requirement bites. It also had to split the absolute-spending scoring band in two after industry consultation. The July draft criteria had applied a single band regardless of company size. Under the final rules, a company below KRW 100 billion in sales needs a three-year average of KRW 45 billion a year in R&D to reach the top grade; above that line, the top grade costs KRW 100 billion a year. And clinical trials are weighted 5 for phase 3 against 0.7 for phase 1. Results, not intent. Fourteen years in, that scheme is still recalibrating who counts as innovative — and still recalibrating in the direction of balance-sheet size. Every adjustment described above is an attempt to stop an absolute-spending measure from simply ranking companies by how large they already are. Transposed to cosmetics unmodified, an R&D-spend gate certifies manufacturers and misses exporters. Not through any bad intent. Through the arithmetic of the measure itself. What does "overseas expansion capability" mean? Nothing yet. And that is the most consequential blank in the statute. Written lazily, it becomes export revenue — which certifies whoever is already winning and directs support to the companies with the least need of it. Written well, it measures what actually separates a brand with a foreign market from a brand with a foreign order: Whether the product registration in the destination market is held by the brand or by its distributor. Whether the Responsible Person under EU Regulation (EC) No 1223/2009 answers to the brand owner or to somebody else. Repeat orders as a share of total orders. Whether a distributor relationship survives its second year. Those four things are the difference between an export figure and an export business, and none of them is currently collected anywhere. Which makes the three-yearly state-of-the-industry survey — easily the dullest clause in the Act — the one worth watching. What the survey measures is what the certification can eventually reward. The image illustrates a stylized exchange of documents, with one person handing papers to another across a desk, symbolizing communication and transfer of information. When does the Act take effect, and what should exporters do now? The Act takes effect one year after promulgation. The consultation on subordinate legislation runs across that year, and the ministry has said it will gather views from industry, experts and other ministries before drafting the enforcement decree and enforcement rules. That consultation is the event. Not the vote. If your export capability is real but does not show up as an R&D line item on your accounts, the window in which that can be argued is open now and closes when the decree is finalised. The submissions that shape it will come from whoever bothers to make them, and the tiers most affected by an R&D-spending gate are also the tiers least likely to have anyone whose job is to file a policy comment. The vote was the easy part.

The Korean Intellectual Property Office is registering a K-Brand certification mark in 70 export countries and holding the rights itself. That choice of legal instrument is the argument: a certification mark exists precisely because the thing being protected belongs to a whole class of producers rather than to any one of them. This piece sets out why "K-beauty" is a country-of-origin commons rather than brand equity, and what a Korean exporter actually owns once the adjective is removed. Twin towers housing the Ministry of Intellectual Property, surrounded by a modern cityscape and green spaces. What did Proya announce, and why does it matter to Korean brands? The clearest statement about K-beauty's next decade was issued from Hangzhou, not Seoul. On 19 August, Proya Cosmetics announced that Proya, its flagship brand, will launch its Advanced Firming and Original Repair collections in 400 Ulta Beauty stores and on Ulta.com this November. Ulta says it has more than 1,500 stores in the US. The interesting part is not the door count. It is that the release names its own thesis in a subheading: From "Product Export" to "Global Brand Building". Yuli Cai, head of Proya's overseas business, is quoted saying that global expansion "means earning a lasting place in consumers' daily skincare routines", and that the partnership is "an important step in building PROYA as a global beauty brand". That is company marketing and should be read as such. But the architecture it describes is checkable, and it is unusual: two named collections with stated mechanisms — a peptide-retinol anti-ageing range, a barrier-repair essence — proprietary patented technologies, clinical validation, refillable packaging on the firming line. Delete the word "Chinese" from every sentence of that release and the proposition still stands up. Now run the same deletion on most Korean brands entering the same market. Innovative design sketch of a spray bottle against a vibrant turquoise background, ⓒinhoocho.com What exactly is the KIPO K-Brand certification mark? It is a government-owned badge, registered abroad by the state, that exporters apply for and attach to their own products. The Korean Intellectual Property Office is standing up a K-Brand government certification system. As Seoul Economic Daily reported on 31 March, the government itself registers the K-Brand certification trademark overseas and acts as the rights holder so that it can take enforcement action. KIPO said it would pursue registration in 70 export countries, with exporter applications opening in August. Certified goods carry QR codes and AI watermarks so that overseas shoppers can verify authenticity with a phone camera, and the scan data feeds monitoring. Where the system flags a fake certified product, Personal Care Insights reported on 12 August, Korean authorities will be able to request criminal investigations, searches and customs seizures from foreign governments directly. Why does a certification mark prove that "K-beauty" is not brand equity? Because of what a certification mark is, legally, and what it is not. KIPO is not registering the word Korean, or K-beauty, as a trademark. It cannot. Nobody can. What it is registering is a certification mark — a legal device whose defining feature is that its proprietor does not put it on their own goods, because it exists to let a body vouch for a quality shared across a whole class of producers. It is the instrument you reach for when the thing worth protecting has no owner. That is the definitional point, and it is not a semantic one. A brand is an asset with an owner who can license it, defend it, sell it and lose it. "K-beauty" fails every part of that test, which is why the defence has to be built as a proxy: a state-owned badge standing in for an adjective nobody can own. It is a country-of-origin commons — free at the point of use, available to anyone who can plausibly stand near it, and, like every commons, degraded by whoever uses it hardest. What is actually being copied when a Chinese retailer imitates a Korean one? Not a brand. A nationality — which is why nobody has standing to sue. Korea Customs Service seized some 117,000 counterfeit goods of Korean brands in 2025 and found that 97.7% came from China, with cosmetics the largest category. Personal Care Insights reports Romanian customs seizing counterfeit Medicube items shipped from China at Timișoara Airport. But the sharper example is not a fake at all. A Chinese retailer called Only Young has opened stores copying Olive Young's name, logo design, signature colours and product displays, with K-pop music in its Douyin promotion. A counterfeit serum is a trademark matter with an obvious plaintiff. A shop that merely feels Korean is not. Only Young is renting a nationality rather than copying a brand, and there is no plaintiff in that sentence — which is why the certification mark had to be invented. Vibrant pop art design featuring a repetitive pattern of stylized, ⓒinhoocho.com Why is country-of-origin reputation a subsidy rather than a moat? Because it is free at the point of use, which is exactly what makes it impossible to defend. The commons has been a subsidy, and a good one — it shortens the first buyer conversation and makes the first shelf placement easier to win than it should be. Korean cosmetics exports reached about US$7bn in the first half of this year according to Korean customs, with the US now the largest market, and a great deal of that was won on a category reputation no single exporter paid to build. The trouble with booking a subsidy as a moat is that you find out the difference at the worst possible moment: when a buyer has a page of Korean serums to choose between, or when a competitor decides the adjective is available to them too. How can a Korean brand test whether it owns anything? Delete the country from the deck and read what survives. Here is the audit I would run on any Korean brand's export deck this quarter. Delete the words Korea, Korean and K-beauty everywhere they appear, and read what is left. If slide one was the country and slide two does not exist, you do not have a brand — you have a category position, and category positions are occupied, not owned. The ones that pass hold something with a proprietor: a patented delivery system, a clinical dataset, a controlled distribution agreement, a manufacturing relationship a competitor cannot replicate at speed. Proya's release is a company arguing, at length, that it is building exactly those. Whether it has is a matter for November and for the product. That it is arguing it out loud, in a launch release, is the part Korean brand teams should sit with. I spend the other half of my working life on ingredient sourcing, where "origin" means something else entirely: a documented, auditable claim that costs money to substantiate and is worth something precisely because it does. Cosmetics marketing has had the reverse — origin as a free-floating asset nobody had to evidence or pay for. The certification mark is useful infrastructure, and a government standing behind an authentication badge is more than most exporting nations manage. It is also a floor, not a moat. It stops the worst impersonation. It cannot turn a shared adjective into a private asset, and it was never designed to. A solitary golden rectangle stands prominently against a vast backdrop of clear blue sky and an expansive silver-hued field, ⓒinhoocho.com Doesn't this apply to Swiss watches and French wine too? It does, and that is the strongest objection to everything above. The question I would put to anyone selling Korean cosmetics abroad: if the certification mark works exactly as designed, and every fake is caught, what have you got that a competitor could not have by next spring? The strongest counter-argument is a real one. Category reputations are not nothing, and Swiss watches, German cars and French wine have compounded for a century without any single company owning the adjective. Fair. But each of those rests on an appellation, a hallmark or a technical standard with legal teeth, built over decades — an institution, not a mood. Korea is building its version now. Whether that is early or late is the argument worth having.

Amorepacific's Mamonde began selling exclusively on Nykaa this month at a price below most of the Korean brands already on the platform. Two of those brands, Laneige and Cosrx, belong to Amorepacific. This piece sets out why a single dominant platform is the one place a multi-brand group cannot hide its own price ladder, and what that costs the brand placed at the bottom of it. Mamonde products now available at Nykaa, ⓒNykaa What did Amorepacific actually launch on Nykaa? Ten products, one platform, and a deliberate position at the accessible end of the Korean range. The Korea Herald reported on 18 August that Mamonde has begun selling exclusively on Nykaa, India's largest beauty e-commerce platform, with a line-up priced below most of the Korean brands already on its shelves. The ten products are drawn from two lines. Rose HA is built on damask rose extract and five hyaluronic acids of differing molecular sizes, aimed at hydration. Peony BHA pairs peony extract with beta hydroxy acid to address pores and excess oil. The company says the selection reflects a reading of Indian skin concerns derived from local climate conditions — strong ultraviolet exposure, high temperatures, and humidity that varies by season — which put dehydration, oiliness and enlarged pores at the top of the list. K-beauty in India, the paper notes, has largely arrived on the premium end. Mamonde is positioned as the lower-cost entry point. Exclusive display of a cosmetic collection showcased on a sleek counter, with an artistic illustration style, ⓒinhoocho.com Which Korean brands were already on Nykaa, and who owns them? Eight of them — and the ownership is the part every account of this launch has read straight past. The Korean brands already selling through the platform, per the same report: Medicube, d'Alba, Skin1004, Beauty of Joseon, Laneige, Cosrx, TirTir and Dr. Althea. Read that list again. Laneige is an Amorepacific brand. Cosrx has been an Amorepacific subsidiary since the group exercised its call option in October 2023, taking its holding to roughly 93 per cent. So this is not a story about a latecomer squeezed by faster rivals. It is a group adding a third brand to one platform, positioned below two rungs it already owns. Why does a single platform change how a brand portfolio works? Because it removes the distance that made price tiering survivable in the first place. Multi-brand groups have always tiered by price. What has historically made that workable is that the tiers lived in different places. The prestige brand sat in a department store, the mass brand in a supermarket, the clinical brand in a pharmacy. A shopper had to physically travel between them to make the comparison. The architecture was legible to the company and invisible to the customer, and that gap is precisely what made it work. Nobody stood in one aisle weighing three of the same group's brands against each other, because nobody could. A single dominant platform removes the travel. On Nykaa, Laneige, Cosrx and Mamonde occupy one grid. The shopper can sort by price. There is no fixture, no shelf adjacency, no sales assistant, and no distance — only three products from one owner, ranked. My reading, and the reporting does not say this, is that in that setting a portfolio stops being an architecture and becomes a comparison. A vibrant pattern of blue and orange abstract bottle illustrations arranged in rows on a bold background, creating a striking visual symmetry, ⓒinhoocho.com Does the exclusive Nykaa tie-up make the problem worse? It does, and this is the detail most likely to be filed as a positive. An exclusive platform partnership reads as commitment, focus, and a cleaner launch. It also removes the group's only structural escape route. Mamonde is not on Nykaa alongside other Indian channels. It is on Nykaa and nowhere else. Whatever separation the group might have engineered between its three brands — different retail environments, different shopper missions, different moments of encounter — is unavailable, because there is only one environment. The tiering therefore has to be carried by the products themselves, in a grid, against sister brands with a similar Korean skincare pedigree and a similar visual language. That is a great deal of work to ask of a bottle. What is the narrative cost of a premium story at an entry price? Both exits close behind you. A Mamonde official told the Korea Herald the brand builds on more than thirty years of flower research. The India range leads with that inheritance: damask rose, five molecular weights of hyaluronic acid, peony. Provenance, long-run laboratory work, a specific botanical claim. That is a premium story being retailed at an entry price, one scroll away from a sister brand carrying a comparable Korean skincare pedigree at a higher one. Raise the price later and you repudiate the shelf placement that recruited your first buyers. Cut the specification to fit the price and you repudiate the story that justifies the brand's existence. Companies in this bind usually do neither. They stay where the platform put them. Is this the same pattern as Beauty of Joseon in Coles? The same week's reporting shows the wider version of it, in a different market and a different channel. KED Global noted on 18 August that Beauty of Joseon, owned by Goodai Global, has entered 800 Coles stores in Australia. It framed the broader shift as brands moving beyond online virality to secure supermarket and platform retail access as competition intensifies, attributing that reading to industry sources. That framing is correct as far as it goes. It just skips the part where the shelf, not the brand book, is now where tiering actually happens. Securing access is the visible achievement. Deciding what tier you occupy once you have it — and who you are ranked against when you get there — is the decision that outlasts the launch. A busy scene in a bright store aisle, where a worker restocks cosmetic products on the shelves as shoppers browse for their favorite items, ⓒinhoocho.com What should Korean brands take from this? That none of it makes the launch wrong, and that the question worth asking is a narrower one. India has real headroom. An exclusive platform tie-up is a sensible way in. A brand that arrives affordably and earns its way up has been done successfully before, more than once. The point is narrower than a verdict on the launch. The decision that mattered was not which market to enter. It was where to stand relative to brands the same group already sells there. Korea exported $11.4 billion of cosmetics in 2025, overtaking the United States to stand second in the world behind France. That figure measures how much product left the country. It says nothing about whether the brands that left are being compared to strangers, or to each other.

On 18 August, CVC Capital Partners subscribed KRW 300bn of new Silicon2 shares — about USD 212m — at a premium, taking 9.23% of a company that owns no beauty brand at all. Six months earlier, Goodai Global had bought the distributor Hansung USA to take its North American supply chain in-house. This piece reads the two deals as the same structural problem solved from opposite ends, and sets out what the aggregator model actually leaves a Korean brand holding. What did CVC Capital actually buy in Silicon2? A position in the layer between a Korean brand and a foreign shelf — not a position in any brand. On 18 August, Silicon2 disclosed a KRW 300bn third-party allotment subscribed in full by Starlink Investment, a special-purpose vehicle set up by CVC Capital Partners. The terms were 6,666,666 redeemable convertible shares at KRW 45,000 each, 5.64% above the KRW 42,599 reference price, for 9.23% of the enlarged share count. That premium is the tell. An investor buying existing stock pays what the market asks. Paying above the mark for newly issued paper is what you do when you intend to stay in the room. CVC is not a tourist in this category. It runs roughly €212bn — about KRW 347tn — across some 30 offices worldwide, took control of Douglas in 2015, and has invested in the Danish health and beauty chain Matas. Douglas operates around 1,970 stores and sells across 22 European countries. In Korea, CVC already holds strategic positions in Pharma Research, of Rejuran, and Starvision, which runs the O'Lens contact lens chain. Cosmetic bottles travel along a conveyor belt, ⓒinhoocho.com What does Silicon2 do, and why is that a different asset from a brand? It buys Korean indie cosmetics outright and moves them to foreign retailers, and it grows with the category rather than with any one name in it. Silicon2 purchases Korean indie brands' stock directly and supplies it to overseas retailers and distributors, handling sourcing, inventory, local logistics and marketing along the way, with its own StyleKorean.com platform underneath. The structure grows when Korean cosmetics sell abroad, across whichever brands happen to be selling. That is a materially different asset from any of those brands — and it is the asset a private equity house can underwrite, because it does not require a view on which brand is fashionable in eighteen months. How strong are Silicon2's numbers? Strong enough to make the structural argument for themselves. Revenue rose from about KRW 131bn in 2021 to KRW 1.1tn last year. Operating profit went from KRW 8.8bn to KRW 205.4bn over the same period. Second-quarter results, announced on 13 August, put revenue at KRW 402.6bn, up 51.8% year on year, operating profit at KRW 83bn, up 59.0%, and the operating margin back to 20.6%. The regional split is where the story is. Europe contributed KRW 173.4bn, up 62%, through retailers including Boots and Superdrug. North America contributed KRW 87.3bn, up 79%, through Ulta and Target among others. NH Investment & Securities raised its price target to KRW 54,000 and Samsung Securities to KRW 55,000. Why did Goodai Global buy Hansung USA? To stop being a customer of this layer and start owning it. In February, Goodai Global — which owns Beauty of Joseon, TIRTIR and Skinfood among others — acquired Hansung USA, one of Silicon2's competitors, to take direct hold of its North American supply chain and operating infrastructure. Hansung USA had turned over roughly KRW 170bn the previous year, more than double the year before. The market read it as a defection. Silicon2's shares fell 17.26% across February while the KOSPI rose 19.52%, because Goodai accounted for 23.6% of Silicon2's revenue as of the third quarter of 2025. Did losing its biggest customer actually hurt Silicon2? Less than the share price implied, and the reason is the whole argument. The same reporting that carried the 23.6% figure also carried the number that complicated it. Analysts pointed out that Goodai was only 2.7% of Silicon2's US revenue — the concentration was real in aggregate and thin in the market that mattered. Son Min-young of KB Securities put the general case plainly: it is structurally difficult for a single company to supply K-beauty volume exclusively into the world's largest beauty market. Five months later, Silicon2 printed the second quarter above. Both events are the same event, seen from opposite ends. Korean beauty exported faster than most Korean brands built the apparatus to export with — warehousing, customs, retailer relationships, a local team — and something had to sit in that gap. Either the brand acquires it, or the party already sitting there gets capitalised and keeps the category. In a little over six months, Korean beauty ran both experiments in public. Goodai bought a distributor. CVC bought into everyone else's. A detailed illustration captures the storage area of a warehouse, with towering shelves filled with boxes stretching into the distance, ⓒinhoocho.com What does an aggregator actually leave a brand holding? The brand and the formulation. Not the customer. If overseas growth runs through an aggregator, the aggregator holds the retailer relationship, the reorder rhythm, the sell-through data and the local team's attention. You hold the brand and the formulation. That is a real asset and it is not nothing. But it is a smaller share of the total than most founders assume at signing, because the invoicing looks like a wholesale purchase while the relationship is described as a partnership. A solitary cosmetic bottle rendered in precise graphite sits on the expansive left of the canvas, juxtaposed with an intricate assembly of crates and shelves on the right, ⓒinhoocho.com What does it cost to take that position back? An acquisition, not a renegotiation. Reversing the arrangement later is not a matter of better terms at renewal. Goodai's route back was to acquire a distributor outright — a company turning over KRW 170bn a year. Whatever the price, that is the order of magnitude involved in taking the position back. None of which makes the aggregator model wrong. For a brand with twenty people, the alternative is not "own the pipe" — it is "don't export." Silicon2 exists because that trade is worth making, and CVC has now priced it: the growth of the category, largely detached from the question of which brand captures it. What should a Korean brand founder take from this? That capital has made a judgement about where durable value sits in K-beauty, and brands are on the other side of it. The narrower reading of Tuesday is more useful than the funding headline. Capital has concluded that the durable position in Korean beauty is the layer that outlives any individual brand's fashion cycle. If you are a brand, you are on the other side of that judgement. The thing worth building is the thing no aggregator can hold for you — a reason a shopper abroad asks for your name specifically, rather than picking up whatever the Korean section is offering this season. That was never a distribution problem.

On 20 August, nineteen Korean beauty brands enter more than 500 Sephora stores in the United States inside a fixture called the "OLIVE YOUNG K-beauty Edit". The brand doing the launching is Olive Young, and the nineteen are its contents. This piece reads the brand list as a commercial decision rather than a press release, and sets out what a brand inside a curated third-party shelf should be negotiating for. Olive Young K-Beauty Edit at Sephora, ⓒinhoocho.com Which 19 brands are in the Olive Young K-Beauty Edit at Sephora? From 20 August, more than 500 Sephora stores across the United States carry a dedicated section called the "OLIVE YOUNG K-beauty Edit". The Korea JoongAng Daily puts the store count at roughly 580. The nineteen brands, as listed in the joint announcement, are Abib, Arencia, Banila Co, beplain, Bioheal Boh, Cell Fusion C, Fation, Fully, Heveblue, make p:rem, ma:nyo, Menokin, Rejuran Cosmetics, S.Nature, Sungboon Editor, Thome, Torriden, Wellage and Whipped. Sephora's Times Square flagship in New York gets a dedicated Olive Young space. The fixture has a name, and the name is the argument. The retailer's name is on the shelf. The brands are the contents. "Olive Young K-Beauty Edit at Sephora", ⓒinhoocho.com What is Olive Young actually exporting here? A merchandising point of view, sold as a product. CJ Olive Young was established in 1999 and claims 27 years of retail expertise by its own count. Over that period it has built an editorial position on what Korean consumers actually buy. It has now placed that position inside a competitor's estate. The companies describe the arrangement as a first-of-its-kind retail integration, and on that narrow claim they are right. Olive Young already exports its own judgement through its own doors — it opened its first US store in Pasadena on 29 May 2026 and a second in Los Angeles in June. What is new is renting the judgement out to somebody else's shop floor. "Olive Young K-Beauty Edit at Sephora", ⓒinhoocho.com That is a genuinely different transaction from the one the Korean beauty industry has been running for a decade. Until now Korea has exported brands, formulations and manufacturing capacity. This is the export of retail judgement itself. How were the 19 brands selected? By Korean evidence, not American evidence — and the distinction is the whole point. The nineteen were chosen, per the joint release, "for their proven performance, consumer popularity and trend leadership in Korea." Korea. Not the United States. And the choosing was Olive Young's: the release states the brands were "selected by OLIVE YOUNG in partnership with Sephora." So the evidence base for an American shelf assignment is Korean sell-through data, read by a Korean retailer. That is a perfectly defensible way to pick. Olive Young's read on Korean demand is about as well-informed as such a read gets, and betting an American shelf on it is a reasonable bet. It is also a categorically different claim from "these brands have proven they work in America." Nobody has said that, and the distinction matters enormously to the brands concerned, because it determines whose track record is being staked at the till. Does the Sephora line-up match Olive Young's own US stores? Not in what each channel is promoted on. The Pasadena flagship runs about 5,000 SKUs from around 400 brands, organised by skin concern and ingredient rather than by brand. The K-beauty names the company chose to headline in its own launch announcement were Anua, Biodance, fwee, Mediheal, Mise-en-scène, rom&nd, Torriden and Unove. Of those eight, exactly one — Torriden — also appears in the Sephora nineteen. A qualification matters here, and it is worth stating rather than glossing. The full Pasadena assortment has never been published, and the eight names above are explicitly illustrative rather than exhaustive. Given that Olive Young Korea carries all nineteen of the Sephora brands, the real overlap between the two US channels is unknown and probably substantial. But the promotional line-ups are the decision. Two American channels, two different sets of brands pushed to the front, one curator choosing which brand gets which spotlight. For a brand inside the Edit, that is the whole strategic situation in one sentence. You did not win a shelf. You were allocated one. "Olive Young K-Beauty Edit at Sephora", ⓒinhoocho.com What does the fine print say about how permanent this is? Less than the word "partnership" implies. The release carries an asterisk most readers will skip: "Brand curation may vary depending on in-store space allocation and whether a brand is available exclusively online." Doors are not guaranteed brand by brand. Some of the nineteen will be online-only in practice. Olive Young has also said it intends to refresh the line-up twice a year. That is a useful number to sit with. It tells you how permanent a place in the Edit is meant to be, and it converts an abstract risk into a date. This is a supply relationship dressed in the language of partnership. The asymmetry is not concealed — it is disclosed in a footnote. Olive Young, ⓒCJ Is this a bad deal for the 19 brands? No. It is an extraordinary deal, and anyone would sign it. Try naming Fation, Heveblue, Menokin, Thome or Whipped unprompted as an American shopper. These brands are about to receive distribution that would take a direct-to-consumer brand five years and a great deal of money to build, on the strength of a Korean retailer's badge rather than their own reputation. The question is not whether to sign. It is what any of them owns on the day the fixture is reset — and the company has told them that day comes twice a year. Why does narrative ownership matter more than distribution now? Because narrative equity is not a by-product of distribution. It has to be built deliberately, and curated third-party retail works against it. The shopper's mental model coming out of that bay is "I bought it from the Olive Young section," not "I bought Menokin." The credibility spent at the till belongs to the curator, and when the bay is reassigned the curator keeps it. The macro numbers make the stakes concrete. Korea exported a record 11.4 billion dollars of cosmetics in 2025, second in the world behind France at 24.3 billion dollars and ahead of the United States at 10.8 billion dollars. The US is now Korea's single largest destination at 2.2 billion dollars. At that scale, distribution has stopped being the binding constraint on Korean beauty. Narrative ownership has become it. There are enough Korean brands on enough American shelves that shelf presence no longer differentiates anything on its own. "Olive Young K-Beauty Edit at Sephora", ⓒinhoocho.com What should a brand negotiate for inside a curated shelf? Not margin, and not door count. What accrues to the brand while the arrangement lasts. Four things are worth more than a point of margin. Whether the brand can run its own in-store sampling rather than relying on the fixture to do the selling. Whether it sees any customer data at all, or whether the relationship terminates at the retailer. Whether the Edit's shelf-talkers and packaging conventions allow a founder story to appear, or flatten every brand into house style. And whether the deal buys a route to a standalone Sephora assortment, rather than permanent residency inside someone else's section. The last of those is the one that compounds. A brand that graduates out of the Edit into its own bay has converted borrowed credibility into its own. A brand that stays inside it for five years has rented shelf space at a very good rate and built nothing it can take with it. How will we know whether the 19 brands built anything? There is a test, and it is measurable. Twelve months from now, ask American shoppers who bought from that bay to name what they bought. If they name brands, the nineteen built something real. If they say "the Olive Young shelf at Sephora," then one Korean company internationalised on 20 August 2026 and nineteen supplied it. Recognising which of those you are is the difference between a launch and a purchase order.

The fluorescent lights of an OEM manufacturing plant in Incheon do not sleep. While marketing executives in Manhattan debate the aesthetic appeal of snail mucin, stainless steel reactors in South Korea are churning out custom formulations in forty-eight-hour cycles. The global fascination with Korean beauty is often framed as a triumph of viral aesthetics—a soft-power wave of pastel packaging, glass-skin tutorials, and influencer endorsements. Yet, beneath this polished exterior lies a brutally efficient industrial engine. The real story of K-Beauty is not about gentle botanical extracts. It is about cold, ruthless speed, supply chain supremacy, and an algorithmic response to consumer impulse. The Illusion of Culture Hides a Machinery of Speed To view the rise of Korean skincare merely through the lens of cultural resonance is to miss the entire architecture of its dominance. Western beauty conglomerates historically operated on an eighteen-month product development cycle, bogged down by bureaucratic R&D and rigid distribution channels. Korean manufacturers inverted this model entirely. By coupling hyper-agile Original Design Manufacturing (ODM) infrastructure with real-time digital feedback loops, they reduced the lab-to-shelf timeline to weeks. This structural agility turns trend forecasting from an art into a automated science. When a specific ingredient or texture gains traction on social media, the Korean supply chain does not conduct months of focus groups; it reformulates, repackages, and ships. The global consumer buys into a lifestyle, but what they are actually consuming is the ultimate realization of fast-fashion logic applied to dermatological chemistry. The competitive moat was never the formula itself—it was the speed of the assembly line. Eye-level view of a modern Korean beauty product manufacturing facility Compliance and Data Are the Real battlegrounds The romantic narrative of K-Beauty collapses the moment a shipment hits a foreign customs checkpoint. As the industry matures, the friction between speed and structure becomes painfully obvious. The true differentiator between a transient viral hit and a sustainable global enterprise lies in two unglamorous arenas: regulatory maneuvering and predictive inventory management. Regulatory Warfare as an Asset: International expansion routinely founders on the rocks of local compliance. Ingredients deemed standard in Seoul are flagged by the FDA or EU regulatory bodies, turning massive inventory shipments into expensive liabilities. Brands that thrive do not treat compliance as a final checkpoint; they build regulatory agility into the initial formulation phase, turning localized safety standards into a barrier to entry for slower competitors. The Omnichannel Illusion: Digital-first strategies built early momentum, but pure-play e-commerce rapidly reaches a ceiling of customer acquisition costs. Modern scale demands a hybrid presence—pop-up retail, experiential touchpoints, and physical shelf space—backed by real-time inventory analytics. Without integrated supply chains that dynamically balance stock between physical warehouses and digital storefronts, brands suffer from chronic stockouts or ruinous overproduction. The Personalization Trap: The market is flooded with claims of hyper-personalized, AI-driven skincare. Yet, customization is useless if the manufacturing backbone cannot support batch-of-one production. True personalization requires flexible manufacturing protocols that can tweak formulations without destroying margin structures—a capability that separates true innovators from brands simply wrapping old formulas in new digital surveys. The Modern Apothecary Runs on Logistics, Not Magic The consumer imagines a boutique artisanal process, but the operational reality resembles a high-throughput fulfillment center. Trust in global e-commerce is not built on brand storytelling alone; it is secured through direct-from-factory sourcing guarantees, transparent tracking, and seamless cross-border logistics. Platforms and brands that control the pipe between the laboratory floor and the end-consumer's doorstep hold the true leverage. When international brands seek to partner with Korean supply networks, they often mistake surface-level product features for the underlying formula for success. They attempt to replicate the packaging or copy the ingredient list, failing to realize that the product is merely an ephemeral output of an integrated system. Without the localized market intelligence, cross-border shipping infrastructure, and quality control systems that support the physical product, foreign market entry becomes an exercise in burning capital. Close-up view of a well-organized Korean beauty product display in an online warehouse Survival Belongs to the Mechanized, Not the Charming The next iteration of the beauty industry will not be decided by who tells the most compelling story on a screen. As the market enters a mature phase, technological forces—microbiome biotechnology, sub-surface skin mapping, and closed-loop circular packaging—will raise the cost of entry significantly. The era of relabeling off-the-shelf formulations and riding a wave of digital hype is rapidly closing. Korean beauty proved that agility could defeat legacy scale. But as global competitors adopt these same supply chain mechanics, the strategic advantage shifts back to institutional discipline. Brands that treat K-Beauty as a mere aesthetic trend will inevitably be replaced by the next viral phenomenon. Those that understand it as a precise, technology-driven supply chain mechanism will dictate the terms of the global beauty market for the next decade. The machine does not care about the narrative; it only cares about who controls the operational speed.

East African nilotica shea is not held back by capacity or certification. It is held back by the fact that "shea butter" is already a settled category for most formulators and sourcing managers, and what they settled on is the affordable West African version. A Korean refining hub now forming would solve that — while moving the two most valuable steps in the chain from Uganda to Korea. Why does East African shea struggle to get specified? The obstacle is not capacity and not certification. It is not quite price either, though price is where the problem began. It is that "shea butter" is a solved category in the mind of nearly every formulator and sourcing manager who hears the words, and what they solved for is West African shea. West African shea sits in a low price band and is abundant, and being affordable and abundant for decades is exactly how it came to define the category. In my experience it earns its place on the label far more reliably than it earns its place in the formulation. It goes on the pack because consumers recognise the name. That is a rational use of a commodity input, and it has quietly set the ceiling for everything that shares the name. So nilotica is not building a perception. It is dislodging one. The second is much harder. Is nilotica simply too expensive? Nilotica does cost more; CBI's market guidance puts it above West African shea. But that is downstream of the real problem rather than the cause of it. A buyer who has never felt the difference has no reason to pay for it and no reason to go looking. Price becomes a negotiation only after the category assumption breaks. A collection of ripe Nilotica shea nuts, ready for processing into high-quality shea butter. What happens when someone actually tries nilotica? I watched it happen in about four seconds. A sales rep who had sold shea for years — who knew shea, by his own account — tried East African shea for the first time. He was thrown. He said it was nothing like anything he had used, and what surprised him was the smoothness and how fast it absorbed. Nothing I could have said would have done that. The material did it. What is the actual difference between nilotica and West African shea? The technical basis is not in dispute. Nilotica's oleic acid runs roughly 47% to 67% against 40% to 50% for West African paradoxa, which is why it melts at 25°C to 30°C and gives what CBI calls a balm-to-oil texture — precisely the behaviour Korean skincare builds claims around. But taxonomy does not move purchase orders. Being a different subspecies is an argument; the rep's face was evidence. And there is no HS code separating nilotica from West African shea, so it is invisible in trade statistics. An ingredient that cannot be seen in the data cannot be missed by anyone reviewing them, and cannot be defended by anyone selling it. Hold that thought. The lack of distinct HS codes differentiating Nilotica from West African shea in trade, ⓒinhoocho.com Has the Ugandan supply side actually been built? Yes, and partly with Korean money. The Korea International Cooperation Agency financed a US$5.07 million four-year grant, running 2022 to 2026 and implemented by the International Trade Centre. It was an agribusiness programme rather than a shea programme — the money ran across cassava, shea and oilseed value chains in ten districts of northern and north-eastern Uganda, reaching 10,000 households and 60 SMEs and cooperatives. Shea was one of three chains, which is worth holding on to whenever anyone describes this as Korea funding Ugandan shea. Blessed Organic Release, a woman-led enterprise, aligned its manufacturing to international standards under ITC assistance, signed a first certified organic export contract worth US$80,000, and now coordinates more than 6,000 farmers and moves ten tonnes of certified organic shea butter a year. Exhibitors proudly showcase Nilotica Shea products at the In-cosmetics Seoul event, ⓒITC Can Uganda make finished cosmetic products, or only supply butter? For decades, the global narrative surrounding East African agriculture has followed a familiar, reductive script: the continent exports raw commodities, and the developed world captures the value. In the beauty industry, Uganda's role was presumed to end at shipping unrefined shea butter in bulk to labs in Seoul, Paris or New York. That assumption is increasingly obsolete, and the company I would put in front of a Korean sourcing manager is the reason why. MOHCA Beauty & Skincare is a wholly women-owned enterprise founded in Kampala in 2015. Operating under the SheaCare Naturals brand, it produces more than 25 finished products — raw butter, refined body butters, body and hair oils, lotions, balms, lip balms and facial oils. Every one relies on Vitellaria nilotica, a distinct, oleic-rich shea subspecies, sourced from Uganda's Amuria and Otuke districts. Crucially, MOHCA operates to international standards rather than local workarounds. The company holds ISO 9001, 14001 and 45001 certifications, maintains an EU Registered Exporter (REX) number, and packages for both retail shelves and commercial buyers. For a sourcing director in Seoul or Tokyo evaluating East Africa, MOHCA is a working proof of concept: value addition is no longer an imported service. It is happening on the ground in Kampala. This local manufacturing capacity is now gaining structural weight. In December 2025 the Nilotica Shea Alliance formally launched in Kampala, backed by a governance framework and an elected board. Developed under Palladium's leadership via the UK FCDO-funded Climate Smart Jobs programme — alongside the Global Shea Alliance, TASLAF Advocates, CBI and the International Trade Centre's KOICA-financed initiative — the coalition aims to formalise and scale the sector. Notably, its interim chairperson is Marion Etiang-Busingye, MOHCA's chief executive. Participants at the Nilotica Shea Alliance Meeting pose together, showcasing collaboration and unity in promoting the shea industry across Uganda. Why won't Korean brands import nilotica directly? The demand side is further along than the trade data can show. The founder of a premium aesthetic brand imported small volumes and put them through her own lab. She was interested in the texture and, equally, in the story behind it. But she does not want to keep importing directly: the lead times are long and the documentation is a burden she has no reason to carry. She wants to buy from a Korean supplier. That is the real constraint, and it is not conviction. It is procurement mechanics. Korean ingredient suppliers have understood this and approached the Ugandan SMEs about localising. A hub is taking shape. Once it exists, buyers anywhere will source refined nilotica from Korea rather than Uganda. Which step in the value chain is actually at risk? Here it is worth being precise about what actually moves, because the West African comparison only holds if you get this right. There is a ladder: nut, crude butter, refined butter, formulated product, each rung holding more margin than the one below. West Africa's export bans were a fight over the first rung — keep the nuts home, press the butter there. Mali restricted raw nut exports in October 2024, Côte d'Ivoire in January 2025, Togo in April, Nigeria in August; Ghana is running a phased restriction and weighing a full ban before the end of 2026. It moved the trade. Shea butter imports hit 27,951 tonnes in the first quarter of 2026, up nearly 27 per cent on 22,046 tonnes a year earlier and the highest first quarter in five years, while nut imports fell 25 per cent to 84,705 tonnes. The advisory N'kalô, in a 5 June bulletin citing customs data, attributes the shift to European manufacturers "buying more butter and investing in local processing to offset the scarcity of raw nut exports." Shea Nut Supply Decline: Illustrative depiction of the shrinking availability of shea from West Africa, ⓒinhoocho.com Uganda is already past that rung. What leaves the country is butter, not nuts. Nobody here is fighting to stop raw nuts departing. So the rung at risk in the Korean arrangement is not pressing. It is refining and formulation — the third and fourth steps, where the margin is, and the ones MOHCA already performs. That is the refined-oil model, and the economics are the whole point of the name: value is added at the destination rather than the origin, and the destination keeps the difference. West Africa climbed one rung by force. Uganda would be handing down two by agreement. Should the hub be built anyway? I am not against the hub. The case for it rests on logistics: without local inventory to keep lead times predictable and customs paperwork off the buyer's desk, brand founders rarely place a second order. In trade infrastructure, reliability is marketing. But a hub built as a destination rather than a stage would duplicate — and in time eclipse — a certified manufacturing capability that already exists in Kampala. Nilotica Shea Kernel, ⓒinhoocho.com And here is what makes it hard to argue about afterwards. Nilotica has no Harmonized System code of its own; it is lumped in with generic shea. There is no customs series showing how much nilotica leaves Uganda, in what form, or at what declared value. If refining moves to Korea, nothing in the official data will record that it moved. The Nilotica Shea Alliance will have no numbers to put on the table when it wants to renegotiate. Which is why the terms being drafted now matter more than the volumes. The discussions are early — one Korean supplier, a handful of Ugandan SMEs, nothing signed. That sounds small, and it is exactly why it matters. Whatever those first few accept becomes the template. The next supplier to join will be offered the standard arrangement, and the standard arrangement will be whatever the first agreement said. One buyer negotiating with several sellers one at a time is the weakest position those sellers will ever be in. The Nilotica Shea Alliance exists so that they do not have to stand in it separately. A common clause — an explicit path up the ladder, refining and then formulation, rather than a permanent role at the bottom of it — is worth more agreed once now than fought for later by each member alone. Korea is about to become a major customer for East African shea. Whether it also becomes the ceiling on that ladder is being decided right now — in contract language, not in policy documents.

Mayacrew CEO Jun-ho Oh A single red light stood between life and death for one young man. When Jun-ho Oh, CEO of Mayacrew, decided to launch his company, it wasn’t in a sleek, modern conference room—it was on a hospital bed. While serving in the Conscripted Police (Korea's conscript-staffed auxiliary police force), he survived a devastating traffic accident that hurled him onto an eight-lane highway. The 30 million KRW (~$22,000 USD) he received in insurance compensation—literally the price of his second chance at life—became the foundational launching pad for Mayacrew. His journey ranges from the raw hustle of visiting up to 400 restaurants a day only to have doors slammed in his face, to spending over $20,000 a month on server costs to crack the U.S. TikTok ecosystem—ultimately earning an organic product endorsement from pop star Cardi B. Yet behind these remarkable data-driven achievements lies the profound trauma of a leader who had to tearfully draw a line through the names of dedicated employees just to keep the business alive. When I first met him last year through a mutual acquaintance, none of this intense grit was immediately apparent. He came across simply as a bright, personable young founder. Even when discussing major milestones, his response was always grounded in humility: "I was just lucky, and I owe it all to the people around me." As our conversation unfolded, that modesty confirmed a rare depth of character. It became clear why anyone who comes to know him naturally ends up rooting for his success. Having built a venture from the brink of tragedy, CEO Jun-ho Oh now sets his sights on building a world-class, defining enterprise. Here is his story of survival, resilience, and the true essence of business. Q1. I heard you used the insurance payout from a major traffic accident during your military service as your initial seed capital. How did that near-fatal moment shape your decision to start a business? I was serving in the Conscripted Police at the time. I was out on leave, riding on the back of a senior officer's motorcycle on our way to Paldang Dam for some fresh air, when a car making an illegal U-turn hit us head-on. The impact launched me completely into the oncoming lanes. It was a massive road—eight lanes wide—and by sheer luck, the traffic light for the oncoming direction was red, so all the cars were stopped. If that light had been green, I would have died instantly. My hip joint was shattered, leaving me completely bedridden and unable to even raise my hips off the bed for two full months. Lying in that hospital bed, my mind ran wild, and my entire life flashed before my eyes. Looking back, I realized I had nearly drowned twice as a child, and this was already my third or fourth major car accident. Every single time, I had miraculously survived by a hair's breadth. Suddenly, I remembered the arcade machines outside stationery stores from my childhood. Even when your character dies, if you insert a 100-won coin, it makes a chime and gives you a fresh life. I thought to myself: "I clearly died in this game called 'my life,' but did God secretly insert a coin on my behalf to bring me back?" CEO Jun-ho Oh lying in a hospital bed following his traffic accident. (Photo courtesy of Jun-ho Oh) That thought sent chills down my spine, and a profound fear took over. "What if this was the final coin God gives me?" I imagined a scenario where I lived a completely ordinary life—working a corporate job, getting married, living until 80 or 90—and upon dying, time-looped back to my 20s in that very hospital room. How would I want to live the rest of my time? The conclusion was crystal clear. Climbing the corporate ladder, chasing prestigious university degrees, and playing it safe no longer mattered to me. Since this was a borrowed life anyway, I developed an unshakeable boldness: even if I hit rock bottom and failed completely, it wasn't like I would starve to death in Korea. I resolved to walk the path of an entrepreneur—someone who could fully pursue what they love and prove their own purpose for existing. That 30 million KRW payout, the literal price of my survival, became the bold starting point for Mayacrew. Q2. When you decided to drop out of university, how did your family and those around you react? To be honest, until I finally made the call during my sophomore year, I was consumed by intense anxiety and internal conflict. For someone in their early 20s, stepping off the path that everyone else considers "the right answer" isn't as easy or fearless as it sounds. My friends and society at large viewed a college degree as a guaranteed insurance policy for a stable future. When they saw me throwing away that safe haven to leap into the unknown, almost everyone tried to stop me. They asked, "Why are you taking such a reckless risk?" or "What if you regret this later?" I was met with harsh skepticism, and honestly, there were moments I felt deeply confused, wondering if I was making a terrible mistake. CEO Jun-ho Oh in a mentoring session with Go Venture Forum Chairman Young-ha Go during the company’s early days. (Photo courtesy of Jun-ho Oh) However, my parents—whom I expected to be my biggest hurdle—had an entirely different reaction. Having watched me closely for years and understanding my true disposition, they deeply respected the conclusion I had reached after such a profound personal crisis. Rather than opposing my decision, they affirmed who I was, saying, "You are someone who needs to fully pursue what you believe in." Thanks to that warm vote of confidence from my family, I was able to shed my fear of risk and find the courage to step out into the wild. Q3. I understand you lived closely with other early-stage founders in a community called 'Gwang-in Hoe-kwan' (House of Madmen). How did that shared experience serve as an emotional anchor and strategic turning point in shaping your early entrepreneurial mindset? It didn't start with any grand master plan. I randomly received a KakaoTalk message asking, "What if a group of founders our age lived under one roof and built a tight-knit brotherhood?" At the time, as novice entrepreneurs fighting lonely battles on our respective front lines, we desperately needed an emotional safety net where we could lean on one another. That single message led me to join the community, and we ended up living together for five years. The greatest asset of our household was a culture of total non-judgment. Outside, the world was constantly measuring and evaluating us through cold, analytical lenses. But inside that house, no matter how reckless or crazy an idea I pitched, everyone backed me up 100% with unconditional emotional support. Knowing I had a safe harbor to return to even if I failed was the single biggest anchor that kept my mental toughness intact along a very lonely path. Living together with the "Gwang-in Hoe-kwan" (House of Madmen) community in the early days. (Photo courtesy of Jun-ho Oh) The real shift in my business philosophy came from watching Jin-woo Kim, CEO of LINER, up close every day. Seeing how intensely he poured himself into his business taught me what real hustle looks like. More importantly, for four or five years, he persistently confronted me with one question: "Jun-ho, your dreams are too small. You need to think much bigger." That challenged me to completely discard my 'small business owner' mindset, which until then had been content with modest local revenue. It served as a defining milestone that inspired me to set my sights on the massive U.S. market and dream of capturing the global marketing ecosystem. Q4. You launched your startup after noticing that the steep discounts offered by first-generation social commerce platforms rarely translated into repeat customers. How did your initial business model prevent one-off marketing losses for small business owners and still build a sustainable growth loop? When I was fleshing out my first venture, the main thing I zeroed in on was the fatal flaw of those first-generation social commerce platforms. Back then, companies like Coupang and Ticket Monster were handing out 50% discount coupons right and left. While that strategy seemed great for driving an initial influx of foot traffic, a closer look revealed a critical issue: repeat visit rates were under 5%. Customers would simply exploit the heavy discount and never return, making it a bottomless pit for business owners. They were bleeding money with zero long-term retention—it was completely unsustainable. To solve this, I flipped the script entirely. Instead of focusing on "How do we get this specific customer to return?", I asked, "How do we use this customer's review to bring in the next new customer?" I designed a virtuous cycle where even if a single customer didn’t return immediately, their online review would continuously attract other new diners. To make that work, we couldn't just hand out coupons indiscriminately. Instead, we created a targeted system that exclusively offered perks to creators with verified online influence. We developed a refined mechanism where the size of the discount was tied directly to the influencer's actual reach. Rather than business owners unilaterally absorbing marketing losses, we established a mutually beneficial model: "If you extend this hospitality, the influencer will repay you with tangible promotional reach and new customers." This structure prevented senseless marketing losses for business owners while building a sustainable, win-win ecosystem for both the venues and our platform. Q5. In the early days of Supermembers, you were visiting as many as 400 restaurants a day, facing constant rejection. What did you learn from that seemingly reckless, cold-calling grind? At the time, our team consisted of just three people: myself, our Chief Operating Officer, and a developer. We needed to build the app, but our developer estimated it would take at least three months. Running on a tight budget with time working against us, we couldn't afford to sit idle for a quarter. I realized that if we wanted venues ready to use the platform the moment it launched, we had to onboard business owners in advance. So, without a finished product or an operational marketing service, we printed flyers and hit the streets. The COO and I would arrive at a commercial district and split up: "You take the right side, I’ll take the left, and let’s meet at the end of the alley." Between the two of us, we did raw street-level sales—pounding the pavement, walking into restaurants, and working every building from top to bottom. CEO Jun-ho Oh and his COO distributing flyers in the company's early days. (Photo courtesy of Jun-ho Oh) Over those three months, we walked into roughly 20,000 restaurants. If the owner was there, we pitched them directly; if not, we asked the staff to pass along our material, offering a free one-month trial upon sign-up once we launched. Out of 20,000 visits, we managed to sign up just 20 venues—a dismal conversion rate of 0.1%. Looking purely at the metrics, anyone would say the idea was dead on arrival. But for me, those 20 sign-ups gave me the absolute confidence that we had enough to launch. More importantly, that grind gave us a masterclass in the real, ground-level pain points of small business owners. For these proprietors, marketing options were extremely limited, making blog marketing virtually their only viable channel. However, because the space was rife with predatory, fly-by-night agencies that would scam owners, shut down, and reopen under a new name, deep-seated distrust was everywhere. The moment the phrase "blog marketing" left my mouth, owners would routinely tell me to get out. Facing that deep skepticism was undeniably tough at first. So, we adapted our strategy. Instead of pitching a service, we opened with: "We're university students building a marketing tool for local businesses." Surprisingly, owners lowered their guard and listened. We’d say, "We're students building this platform to help local spots. If you sign up early, we’ll give you a free month—could we get two minutes of your time?" That subtle shift opened doors. Those first 20 venues—scraped together by three founders with nothing to their names—became our launchpad. By validating real market demand on foot before writing a single line of production code, we laid the foundation for a platform that now serves over 3,000 merchant locations. Q6. While many startups pour their energy into fundraising, Mayacrew chose to survive on organic revenue without taking outside investment. What drove that strategic decision? A lot of people assume I turned down investment out of some grand strategic foresight or pure stubbornness, but that couldn't be further from the truth. In the early days, like any other startup, we were desperate for venture capital and actively pitched VCs. However, from their perspective, the blog marketing market was already an oversaturated red ocean. It wasn't that we chose not to take venture capital—the market simply wasn't giving it to us. Yet, what started as a forced path turned out to be a massive blessing in disguise. By avoiding external capital, we gained absolute operational autonomy: the freedom to make swift, decisive calls without needing anyone else's permission. Had we diluted our equity for VC money, we would have exhausted immense energy convincing shareholders every time we wanted to pivot or iterate. Instead, when I decided to shift our focus to capturing the U.S. marketing space—or when we had to dismantle a growing service overnight to pivot—I was able to execute those calls instantly based on my own conviction. Watching investor-backed commerce companies struggle under intense exit pressure whenever market conditions turned made me realize that preserving Mayacrew's relentless agility was an incredible advantage. Of course, bootstrapping came with painful, concrete opportunity costs. If we had been well-funded, we could have poured millions into aggressive scaling the second our data validated a clear market opportunity, taking over the market in one fell swoop. Instead, bound by our cash balance, our growth timeline was naturally delayed. The real reckoning came toward the tail end of the COVID-19 pandemic, when our financial reserves were completely exhausted, pushing us to the absolute edge. Ultimately, while those trade-offs were grueling, enduring that crucible forced us to build self-sustainability and survival instincts directly into our DNA. If we had been a flashy startup dependent on external capital injections, we would have gone under long ago. But the operational resilience forged through this independent route is precisely why we are consistently profitable today, with annual profits reaching between $1.5M and $4M+ USD while growing on our own terms and pursuing much bigger ambitions. Q7. When the small business sector was collapsing during COVID-19, you faced an extreme crisis. As CEO, how did you navigate that moment when you were at your most vulnerable? The real crisis didn't hit us during the height of COVID-19, but rather in early 2023 as the pandemic was winding down. At the time, our B2B marketing service, 'Superchart,' was showing strong growth trajectories. Blinded by the belief that we had to capitalize on three years of pent-up post-pandemic demand, I hired far too aggressively, completely missing the fact that Q1 is the ultimate off-peak season for corporate B2B marketing as large enterprises are only just setting their annual budgets. As 2023 kicked off, revenue plummeted off a cliff, leaving us $40,000 short for that month's payroll. Both the company's reserves and my own mental stamina were so depleted that a light breeze could have knocked us over. Oddly enough, what kept me from giving up was an Elon Musk motivation video I replayed endlessly on YouTube. The story of Musk facing the simultaneous collapse of Tesla and SpaceX—split-funding his remaining fortune across Tesla and SpaceX to keep both "children" alive—struck a deep chord. I asked myself: "As a parent to Mayacrew, am I putting my life on the line to keep my child alive?" The honest answer was no. That moment of clarity triggered a fierce response. To cut out all mental noise, I locked myself into an uncompromising daily routine. I listened to only one song—'Our Dream' from the anime One Piece—and kept that single 10-minute Elon Musk video on an infinite loop. Every morning, I wrote down five non-negotiable tasks and focused single-mindedly on crossing them off, taking the crisis one day at a time. Driven by a parent's desperation to save a child, I pursued every possible credit line. When my mother learned about the company's situation, she offered her personal savings, saying, "If the company is struggling, take this to keep it afloat." It was the exact amount needed to cover that month's payroll gap. However, family help was only a temporary bandage. Without restructuring our core operations, we were pouring water into a leaking bucket. To survive, we had to cut our workforce by a third to reach immediate breakeven. It remains the most painful and humbling memory of my life, but I had to write out the names of all 20 employees in order of operational priority and draw a cold line across the list. I called each affected team member in one by one, laid bare the company’s bank balance, and was completely transparent: "This is our reality. I can guarantee your full severance pay if we act this month, but beyond this point, survival is impossible. I am deeply sorry." Drawing that line through tears and confronting that harsh reality was devastating, but from May 2023 onward, Mayacrew has not posted a single unprofitable month. While it was a traumatic ordeal caused by my own miscalculation as a leader, it was an invaluable lesson in the true weight of leadership and the responsibility of treating a company as your own flesh and blood. Q8. Out of countless consumer goods, why were you so convinced that 'K-Beauty' could trigger the most explosive data leverage in the U.S. TikTok ecosystem? I had a conviction that for Mayacrew to become a truly great enterprise in the long run, going global was non-negotiable. Looking at the top 100 global companies by market cap as of late 2023, South Korea had only one—Samsung. France, by contrast, had five, four of which were beauty and fashion powerhouses like L'Oréal and LVMH. To compete against global elite players in the U.S. market, I knew we had to leverage our own cultural strengths: consumer goods where we held a distinct advantage. When we conducted deep market research on the U.S. landscape in late 2023, the data pointed unequivocally to one category breaking out at astronomical scale: K-Beauty. While early pioneers like 'Beauty of Joseon' originally opened the doors to the U.S. market, newer players like Anua and Medicube were suddenly generating hundreds of thousands of unit sales on TikTok Shop off a single mega-hit SKU, expanding the market footprint exponentially. Digging deeper into the underlying data, we identified the primary engine behind this trend: TikTok marketing and the rise of "discovery-driven commerce," where content directly triggers instant conversion. U.S. consumers were buying products with their own money, voluntarily uploading video reviews, and generating massive organic viral loops. Cosmetics are the ultimate visual consumer good for short-form video—they offer instant, high-contrast before-and-after transformations and unique texture reveals. The natural synergy between product characteristics and platform mechanics was incredible. All Mayacrew team members on a company trip to the U.S. (Photo courtesy of Jun-ho Oh) K-Beauty was riding the wave of TikTok to generate explosive data leverage that no other consumer category could match. Seeing these clear metrics, I realized this wasn't just a trend, but a fundamental paradigm shift in modern marketing. Influencer marketing and data analytics had been Mayacrew’s core competencies for over a decade. With a massive market opening up right in front of us, there was zero reason to hesitate. Q9. As a communications major, you’re known as a total "data obsessive"—to the point of being the best SQL analyst at the company and pouring an eye-watering sum into web crawling servers every month. What drives this obsession with data from a non-technical founder? It's true—I come from a humanities background in media and communications. I dropped out during my sophomore year to start my business, so I didn't learn much formally at university. But operating Mayacrew over the past decade, I realized that the ultimate core of our business comes down to one question: "How do you quantitatively evaluate an influencer's true impact through numbers and algorithms?" Because I spent sleepless nights manually writing and refining those early algorithms myself, I naturally developed a deep fluency in data. Today, I am still the most proficient SQL user in our company. When helping K-Beauty brands expand into the U.S. market, I refused to rely on gut feelings or industry gossip. Instead, we began scraping the entire U.S. TikTok ecosystem for K-Beauty data. Spending over $20,000 a month purely on crawling servers led many people to call me crazy. However, after six months of persistently aggregating and restructuring that data, the actual structural skeleton of the market emerged—something invisible to the naked eye. We conducted a complete sweep of hashtag volume indicators for K-Beauty brands that achieved massive success in the U.S., such as Anua, Beauty of Joseon, and COSRX. The numbers pinpointed the exact inflection point where marketing transitioned from unpaid product seeding to hyper-scaled affiliate marketing commission models. We captured the precise timing of the success formula through data. Armed with these metrics, our client meetings changed completely. We no longer pitch vague concepts like "TikTok is huge in America right now." Instead, we provide precise, data-driven diagnoses: "This is your current ratio of U.S. versus Southeast Asian content volume. The affiliate conversion spike occurs right here, which means you need to execute this specific campaign immediately." When clients see concrete numbers laid out in front of them, trust is established instantly. Numbers don't lie. Q10. Through this relentless data analysis, what unique operating mechanics and "winner-take-all" secrets did you discover about the TikTok Shop ecosystem? After spending over $20,000 a month in server fees to crawl and analyze six months of U.S. TikTok K-Beauty data, we uncovered a fascinating rule. The key to the TikTok Shop ecosystem isn't simply churning out affiliate videos en masse. When you look closely at the data across various brands, an extreme winner-take-all structure emerges: out of 10,000 videos distributed, only about 300 actually generate meaningful revenue. Even more striking, if a brand hits $1 million in monthly sales, $700,000 to $800,000 of that total is driven by just the top 10 breakout videos. While typical brands rely on gut instinct and think, "Everyone else is pushing 10,000 videos, so we should too," we looked at the data and redefined the game entirely. We stopped chasing raw volume and reframed our strategy around two core questions: "How do we craft those top 10 high-converting videos with precision?" and "How do we recruit the specific creators capable of making them?" Due to TikTok’s algorithmic design, once a User-Generated Content (UGC) framework goes viral, replicating that winning formula with subtle tweaks in setting or staging is what keeps the momentum going. We developed a boosting model: the moment a seeded video breaks out, we immediately request Spark Ads codes (TikTok’s native ad-boosting feature) and back it with performance ad spend, driving down Customer Acquisition Cost (CAC) while scaling exponentially. This data-backed approach produced astonishing real-world results. When we took over agency management for an Olive Young private label brand, we hit $800,000 in monthly sales in just three months. For our next brand, 'Laka,' we generated $250,000 in monthly revenue within just six weeks of launching. Specifically with Laka, as seeded content began going live, we caught an early data signal when one of the first ten affiliate videos crossed $1,500 in single-day sales. Track records like this are exceptionally rare in the current agency landscape. Mayacrew has spent the last decade building proprietary algorithms to quantify influencer impact. Because our team understands data at a foundational level, dissecting the true mechanics of an ecosystem through numbers allowed us to prove that our execution holds a distinct competitive edge on the global stage. Q11. To prove the power of your platform, you launched an in-house brand selling "spicy seaweed" and even scored organic exposure through Cardi B. How did you pull that off? Late one night, my phone blew up with frantic calls and messages from friends: "You won't believe this—Cardi B just posted a video buying, eating, and reviewing your spicy seaweed!" At first, I couldn't process it. My heart was pounding all night, and as soon as morning hit, I rushed to the office and pulled up our TikTok Shop admin console. Product tasting video that generated buzz through Cardi B's organic viral post. (Photo: TikTok) Tracing the transaction history item by item confirmed the reality: no one paid for sponsored placement. Cardi B had purchased our product with her own money and voluntarily posted a review on her personal TikTok account. Truthfully, we created that seaweed brand because we wanted to prove our capabilities with verifiable revenue metrics rather than empty sales pitches. More than that, we desperately needed a private testing lab to validate our data hypotheses. You can't responsibly experiment with client ad spend when testing critical variables—like determining the exact threshold to scale ad budgets on affiliate content or identifying which visual assets trigger the recommendation algorithm. So, we launched our own brand, rigorously tested granular data hypotheses, and executed targeted TikTok seeding. Less than a month after launch, that movie-like breakthrough happened. It was a defining moment that proved a core truth: whether in beauty or food, if you strike the core mechanics of TikTok's algorithm to trigger organic content creation, you can open the wallets of world-class superstars and unlock massive data leverage. Q12. Many beauty brands are jumping at the chance to launch on U.S. TikTok Shop right now. Yet you strongly advise against it, saying, "If you don't have deep capital reserves, don't even look at TikTok Shop." What is the cold reality behind that warning? Because of our track record and the publicity around the Cardi B viral moment, we get inundated with inquiries from brands wanting Mayacrew to manage their TikTok Shop operations. But I'm blunt and direct with them: if a brand lacks financial stamina, they shouldn't even consider TikTok Shop. At its core, TikTok Shop is a game of pure capital deployment. As I mentioned, an extreme minority of top-tier creators drive the overwhelming majority of total sales volume. However, the top 10% of creators who actually convert are already locked down by mega-beauty brands backing them with massive capital. Tarte brand trip hosting influencers on a private jet to an island retreat. (Image courtesy of inhoocho.com) Category leaders like 'Tarte' retain creators by offering astronomical incentives and lavish reward structures. To pull those creators toward a new brand, you have to absorb negative initial Return on Ad Spend (ROAS) and burn hundreds of thousands of dollars a month in ad spend to earn algorithmic favor. TikTok's AI algorithm naturally amplifies advertisers who spend aggressively and generate high engagement. The initial technical barrier to entry is equally steep. Building immediate trust on a fresh TikTok Shop requires established review volume. Sophisticated brands navigate this by using third-party integrations like 'Judge.me' to compliantly sync existing review assets from Amazon or their Direct-to-Consumer (D2C) storefronts. That technical foundation must be built before stepping onto the field. The most dangerous hidden bottleneck, however, is inventory. If a video hits the algorithm and goes viral, sales don't just double or triple—they explode tenfold or more overnight. If you don't have buffer inventory sitting in local U.S. warehouses to fulfill that surge immediately, what happens? TikTok’s algorithm penalizes your account and cuts off traffic distribution. The moment a brand says, "It's going viral! Let's fire up the factory in Korea and ship a container by sea," you lose two months minimum. By the time inventory arrives, reach has cratered to zero and the window has closed. Sustaining hyper-growth requires working capital capable of funding rapid inventory turns. If a brand lacks at least $700,000 to $1 million in deployable capital and a flawless inventory supply chain, running targeted guerrilla campaigns on Amazon Ads is a far smarter, safer strategy for survival. Q13. You compare yourself to Luffy from the anime One Piece, emphasizing flat leadership by saying, "When I don't know the way forward, I figure it out together with my team." Yet there are moments that demand a leader's lonely, autocratic decision. How do you reconcile the dilemma between being a "captain who collaborates" and the "isolated decision-maker accountable for direction"? When you stand on the edge of a cliff where the company's survival is at stake—like deciding whether to forgo venture funding or execute a corporate restructuring—the final signature falls solely on the CEO. That burden is inherently solitary. However, I navigate the dilemma between being a collaborative captain and an isolated decision-maker by strictly separating the deliberation phase from the execution phase. When we lack clarity on where the ship should head, I lay bare my vulnerabilities to my team like Luffy: "I honestly don't have the answer to this. Let's put our heads together." I don't believe a CEO is obligated to have every answer. During our 2023 crisis, when we had to lay out our depleted balance sheet and draw that painful line of restructuring, we didn't hide behind corporate speak. Sharing the raw truth built deep mutual trust, ensuring the team felt empowered to help solve the problem rather than feeling betrayed. However, once we've debated data-driven hypotheses and it's time to set sail—saying, "Alright, we're hoisting the sails in this direction"—I step fully into the role of the resolute decision-maker who shoulders the risk. When I decided to pour over $20,000 a month into server costs to crack the U.S. TikTok market, I planted our flag with the understanding that if it failed, the liability rested entirely on me. It is my job to protect the ship so the team can execute with conviction. The engine of my leadership isn't about projecting flawless authority. It comes from being radically horizontal when seeking wisdom, and radically vertical when taking accountability. Because that foundation of trust exists, my team remains steadfast even when I make bold, high-stakes calls—standing alongside me as true partners navigating rough seas together. Q14. Mayacrew comes across as an organization capable of launching new initiatives and shutting them down at terrifying speed if they miss the mark. How does this decisive leadership style around pivoting operate without unsettling your team? That speed is a direct reflection of my personal operating philosophy: we kill underperforming initiatives fast. We sunset an unpaid seeding platform—one we'd already built to 14,000 U.S. creators—the moment we saw the market shift toward affiliate models. Similarly, after spending six months preparing an Amazon management business, we scrapped it immediately once we saw AI tools handling bid adjustments so effectively that long-term moats were eroding. Whenever we pull the plug on a project, there are naturally voices inside advocating to "give it a little more time." But clinging to a stagnant idea drains organizational bandwidth and morale faster than anything else. I don't make these calls out of 100% certainty; most pivots are probability bets, 60/40 or 70/30. But when I see a 60% probability, I steer the ship without hesitation and own the outcome. More importantly, I share the exact metrics, reasoning, and even my own missteps with absolute transparency so everyone understands why we're pivoting. Mayacrew team members during a "night owl" late-night study session. (Photo courtesy of Jun-ho Oh) I even tell my team point-blank: "I can't guarantee that our main cash cows—Supermembers or TikTok agency services—will exist five years from now. Naver or TikTok themselves could be disrupted by emerging AI platforms." Hearing that from a CEO could easily create anxiety, but I follow up with a core truth: "Platforms may vanish, but two things remain constant: I will be building businesses until the day I die, and Mayacrew's fundamental problem-solving capability is indestructible." I value talent that asks, "What does the company need right now, and where can I create maximum impact?" over individuals who define themselves narrowly by traditional job titles. Our core team has built immense survival instincts across sales, product ownership, and growth marketing. Because our organizational fundamentals are strong, pivoting hard doesn't capsize the ship—it simply allows us to catch bigger waves faster. Q15. At the end of this long voyage, what is the ultimate "One Piece" that you hope to discover alongside your team at Mayacrew? I have very little interest in material milestones like buying expensive cars or luxury real estate. I don't own a car or a home right now, yet I live a deeply fulfilling life. The real driving force behind running this company is answering why I exist on this earth and proving the value of my life. To share a personal perspective, I am a Christian. Within a biblical framework, a meaningful life means taking the talents God entrusted to you and multiplying them to their fullest potential rather than burying them in the ground. In the scriptures, the servant who buried his talent was reprimanded, while the one who cultivated his talents was rewarded. I refuse to place arbitrary limits on my potential; I want to stretch my capabilities as far as they will go and make a lasting mark on the world. The Mayacrew team. (Photo courtesy of Jun-ho Oh) During my formative years at Gwang-in Hoe-kwan, Jin-woo Kim (CEO of LINER) asked me daily: "Jun-ho, why are your dreams so small?" At the time, I didn't fully grasp what he meant. But over time, it clicked: there is no reason to constrain your ambition with current realities. Whether you aim to build a publicly traded company in Korea, list on NASDAQ, or break into the global top 100, reaching extraordinary scale is exponentially difficult regardless. If you're going to place a bet, you might as well bet big. The ultimate destination my team and I are sailing toward is building a defining, world-class enterprise—a global titan out of South Korea alongside companies like Samsung. To me, a true dream exists at the intersection of two things: something so outrageously ambitious that it requires absolute, obsessive execution to achieve, yet so thrilling that just thinking about it makes your heart race. Proving to the world that we can realize that vision alongside extraordinary colleagues—that is the real treasure Mayacrew is building toward.

Amorepacific has put its Anseong health supplement plant up for sale, while LG H&H has opened a preliminary auction for its beverage subsidiary, Haitai HTB. Both actions occurred in July 2026 and are framed as portfolio focus. This framing, however, is both accurate and incomplete. These two companies are clearing assets during the largest export boom Korean beauty has ever recorded. The deficit these sales address—capital and operating efficiency—is not the deficit that cost them their lead. Amore Pacific HQ, ⓒAmore Pacific What Exactly Are Amorepacific and LG H&H Selling? Amorepacific is seeking a buyer for its health supplement manufacturing plant in Anseong, Gyeonggi Province. They have appointed a lead manager to oversee the bidding process. The plant's operating rate fell to 46 percent last year. In the first quarter, production totaled 31 billion won ($21 million), which is less than half of the site's quarterly capacity. Annual output was 171 billion won, down 7 percent year on year. The facility was built in 1989 by Pacific Pharmaceutical, which was renamed Aestura in 2015. It became part of Amorepacific when the company acquired Aestura in 2021. Production will transfer to Amore Beauty Park, Amorepacific's flagship manufacturing complex in Osan. This sale follows the company listing its offices in Busan, Daegu, Daejeon, and Gwangju for sale in November. Amorepacific has made it clear that this is not an exit from health supplements. Cho Yong-hwan, a public relations officer at the company, stated, "We are seeking to sell the Anseong plant to manage our assets more efficiently." He added that the VITALBEAUTIE health supplement business remains core, and this move aims to create synergy between the supplement and beauty businesses. LG H&H is selling Haitai HTB, its wholly owned beverage subsidiary since 2011. Haitai HTB is Korea's third-largest beverage company, following Coca-Cola Beverage and Lotte Chilsung Beverage. Last year, Haitai HTB posted 343 billion won ($233 million) in sales, accounting for 7 percent of LG H&H's EBITDA. A preliminary auction and letter of intent are scheduled for this month. Choi Jin-sung, a public relations official at LG H&H, framed the sale as strategic rather than financial. He remarked, "We are selling Haitai HTB to restructure our strategic portfolio rather than for capital gains or investment recovery." Why Are Korea's Beauty Giants Restructuring During a Record Export Boom? Korean cosmetics exports reached a record $7 billion in the first half of 2026, marking a 27.3 percent year-on-year increase. Korea now stands as the world's second-largest cosmetics exporter. However, almost none of that growth belongs to Amorepacific or LG H&H. Industry observers point to APR and Goodai Global as the companies that have taken market leadership, leaving the two incumbents sidelined during the industry's fastest expansion. The asset sales are widely interpreted as an attempt to regain competitive ground. A 46 percent operating rate is a significant concern, and selling the plant is a defensible fix. However, it is essential to clarify what this fix accomplishes. It frees capital and simplifies the organization, but it does not address why companies holding brands like Sulwhasoo, Laneige, Hera, Aestura, and The Whoo are watching younger companies define what K-beauty means in 2026. Will Buying an Indie Brand Solve It? The anticipated next move—and the one industry observers speculate LG H&H may pursue with the proceeds from Haitai—is acquiring indie beauty brands. However, this move carries a high failure rate due to structural reasons. Formulation is no longer a differentiator in Korean beauty. Essentially, every serious formula in the market is available from a select few original design manufacturers. This is precisely why Kolmar Korea and Cosmax are posting record results while brands fight for position above them. What an indie brand truly owns is a voice: a founder who can articulate in one sentence why the product exists, and customers who can echo that sentiment. Acquisition often undermines this voice. The founder receives a title and a reporting line, while the unique narrative is absorbed into a brand book. Consequently, the asset that justified the price quietly ceases to function effectively. K-beauty Restructuring: Amorepacific & LG H&H's Strategic Asset Sales What Can a Korean Beauty Conglomerate Do That an Indie Brand Cannot? Own time. Amorepacific has conducted ginseng research for decades. The Whoo is built on a Korean court-medicine tradition. Aestura descends from a pharmaceutical company founded in 1989. No brand established three years ago can acquire this depth at any valuation. These are narrative assets, not merely marketing assets—depth that takes thirty years to accumulate and roughly three sentences to explain, if anyone bothers to explain it. Mostly, it is deployed as luxury positioning: heritage packaging, a hanok-inspired counter, or a paragraph in a press release. Positioning tells a customer where to place a brand on a shelf, while a story tells them why to care. Korea's beauty conglomerates have spent thirty years perfecting the first while outsourcing the second. K-beauty Restructuring: The Harder Spend Selling the plant is the right call based on the numbers. However, the next step is to spend a fraction of the proceeds on a more challenging problem: determining whether anyone inside the company can explain, without a deck, why Sulwhasoo should exist in a market that now offers a thousand credible alternatives. If that answer takes more than three sentences, the next acquisition will not resolve the issue either. Korea's manufacturing question is settled. The story question, however, remains wide open—and it is the one the incumbents are best equipped to win, if they choose to treat it as a question at all. In conclusion, the current restructuring efforts by Amorepacific and LG H&H highlight a critical juncture in the K-beauty landscape. As the market evolves, the ability to narrate a compelling story will be just as crucial as operational efficiency. The future of these giants depends on their capacity to bridge the gap between innovation and authentic storytelling, ensuring they remain relevant in an increasingly competitive environment.